147 related articles for article (PubMed ID: 17031553)
21. Temozolomide and thalidomide in the treatment of glioblastoma multiforme.
Riva M; Imbesi F; Beghi E; Galli C; Citterio A; Trapani P; Sterzi R; Collice M
Anticancer Res; 2007; 27(2):1067-71. PubMed ID: 17465245
[TBL] [Abstract][Full Text] [Related]
22. Cervicomedullary tumors in children.
McAbee JH; Modica J; Thompson CJ; Broniscer A; Orr B; Choudhri AF; Boop FA; Klimo P
J Neurosurg Pediatr; 2015 Oct; 16(4):357-66. PubMed ID: 26114990
[TBL] [Abstract][Full Text] [Related]
23. Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas.
Gokce-Samar Z; Beuriat PA; Faure-Conter C; Carrie C; Chabaud S; Claude L; Di Rocco F; Mottolese C; Szathmari A; Chabert C; Frappaz D
Childs Nerv Syst; 2016 Aug; 32(8):1415-23. PubMed ID: 27379495
[TBL] [Abstract][Full Text] [Related]
24. Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.
Hainsworth JD; Shih KC; Shepard GC; Tillinghast GW; Brinker BT; Spigel DR
Clin Adv Hematol Oncol; 2012 Apr; 10(4):240-6. PubMed ID: 22706484
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933.
MacDonald TJ; Arenson EB; Ater J; Sposto R; Bevan HE; Bruner J; Deutsch M; Kurczynski E; Luerssen T; McGuire-Cullen P; O'Brien R; Shah N; Steinbok P; Strain J; Thomson J; Holmes E; Vezina G; Yates A; Phillips P; Packer R
Cancer; 2005 Dec; 104(12):2862-71. PubMed ID: 16315242
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme.
Marx GM; Pavlakis N; McCowatt S; Boyle FM; Levi JA; Bell DR; Cook R; Biggs M; Little N; Wheeler HR
J Neurooncol; 2001 Aug; 54(1):31-8. PubMed ID: 11763420
[TBL] [Abstract][Full Text] [Related]
27. Long-term survival and complete response of a patient with recurrent diffuse intrinsic brain stem glioblastoma multiforme.
Burzynski SR; Lewy RI; Weaver R; Janicki T; Jurida G; Khan M; Larisma CB; Paszkowiak J; Szymkowski B
Integr Cancer Ther; 2004 Sep; 3(3):257-61. PubMed ID: 15312271
[TBL] [Abstract][Full Text] [Related]
28. Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma.
Fried I; Lossos A; Ben Ami T; Dvir R; Toledano H; Ben Arush MW; Postovski S; Abu Kuidar A; Yalon M; Weintraub M; Benifla M
J Neurooncol; 2018 Jan; 136(1):189-195. PubMed ID: 29143272
[TBL] [Abstract][Full Text] [Related]
29. A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas.
Ruiz J; Case D; Enevold G; Rosdhal R; Tatter SB; Ellis TL; McQuellon RP; McMullen KP; Stieber VW; Shaw EG; Lesser GJ
J Neurooncol; 2012 Feb; 106(3):611-7. PubMed ID: 21870118
[TBL] [Abstract][Full Text] [Related]
30. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
Athanassiou H; Synodinou M; Maragoudakis E; Paraskevaidis M; Verigos C; Misailidou D; Antonadou D; Saris G; Beroukas K; Karageorgis P
J Clin Oncol; 2005 Apr; 23(10):2372-7. PubMed ID: 15800329
[TBL] [Abstract][Full Text] [Related]
31. Thalidomide as palliative treatment in patients with advanced secondary glioblastoma.
Hassler MR; Sax C; Flechl B; Ackerl M; Preusser M; Hainfellner JA; Woehrer A; Dieckmann KU; Rössler K; Prayer D; Marosi C
Oncology; 2015; 88(3):173-9. PubMed ID: 25427949
[TBL] [Abstract][Full Text] [Related]
32. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
Fine HA; Wen PY; Maher EA; Viscosi E; Batchelor T; Lakhani N; Figg WD; Purow BW; Borkowf CB
J Clin Oncol; 2003 Jun; 21(12):2299-304. PubMed ID: 12805330
[TBL] [Abstract][Full Text] [Related]
33. Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II study.
Packer RJ; Prados M; Phillips P; Nicholson HS; Boyett JM; Goldwein J; Rorke LB; Needle MN; Sutton L; Zimmerman RA; Fitz CR; Vezina LG; Etcubanas E; Wallenberg JC; Reaman G; Wara W
Cancer; 1996 May; 77(10):2150-6. PubMed ID: 8640684
[TBL] [Abstract][Full Text] [Related]
34. A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme.
Drappatz J; Wong ET; Schiff D; Kesari S; Batchelor TT; Doherty L; Lafrankie DC; Ramakrishna N; Weiss S; Smith ST; Ciampa A; Zimmerman J; Ostrowsky L; David K; Norden A; Barron L; Sceppa C; Black PM; Wen PY
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):222-7. PubMed ID: 18513880
[TBL] [Abstract][Full Text] [Related]
35. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial.
Packer RJ; Boyett JM; Zimmerman RA; Albright AL; Kaplan AM; Rorke LB; Selch MT; Cherlow JM; Finlay JL; Wara WM
Cancer; 1994 Sep; 74(6):1827-34. PubMed ID: 8082086
[TBL] [Abstract][Full Text] [Related]
36. A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas.
Geyer JR; Stewart CF; Kocak M; Broniscer A; Phillips P; Douglas JG; Blaney SM; Packer RJ; Gururangan S; Banerjee A; Kieran MW; Kun LE; Gilbertson RJ; Boyett JM
Eur J Cancer; 2010 Dec; 46(18):3287-93. PubMed ID: 20708924
[TBL] [Abstract][Full Text] [Related]
37. Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.
Hainsworth JD; Ervin T; Friedman E; Priego V; Murphy PB; Clark BL; Lamar RE
Cancer; 2010 Aug; 116(15):3663-9. PubMed ID: 20564147
[TBL] [Abstract][Full Text] [Related]
38. Concurrent carbogen and radiation therapy in children with high-risk brainstem gliomas.
Aquino-Parsons C; Hukin J; Green A
Pediatr Blood Cancer; 2008 Feb; 50(2):397-9. PubMed ID: 17009221
[TBL] [Abstract][Full Text] [Related]
39. Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme.
Del Rowe J; Scott C; Werner-Wasik M; Bahary JP; Curran WJ; Urtasun RC; Fisher B
J Clin Oncol; 2000 Mar; 18(6):1254-9. PubMed ID: 10715295
[TBL] [Abstract][Full Text] [Related]
40. Phase II clinical and pharmacologic study of radiation therapy and carboxyamido-triazole (CAI) in adults with newly diagnosed glioblastoma multiforme.
Mikkelsen T; Lush R; Grossman SA; Carson KA; Fisher JD; Alavi JB; Rosenfeld S
Invest New Drugs; 2007 Jun; 25(3):259-63. PubMed ID: 17080256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]